Stocklytics Platform
Asset logo for symbol IART
Integra LifeSciences Holdings
IART53
$26.05arrow_drop_up1.75%$0.44
Asset logo for symbol IART
IART53

$26.05

arrow_drop_up1.75%
Key Stats
Open$25.37
Prev. Close$25.60
EPS-0.09
DividendNon-Dividend
Next Earnings Date-
Dividend Yield %-
PE Ratio-
LOWHIGH
Day Range23.09
26.29
52 Week Range16.81
45.42
Ratios
EPS-0.09
Fundamentals
Payout Ratio-
Industry average yield2.90%
Last Dividend pay date-
Dividend per share-
Dividend yield forecast-

Stock Analysis

Technicals

Summarizing what the indicators are suggesting.

Strong Buy
Buy
Neutral
Sell
Strong Sell

Analyst rating

An aggregate view of professional's ratings.

Strong Buy
Buy
Neutral
Sell
Strong Sell

Stock Performance

IART-
US Healthcare Sector-
US Market-
check_circle

IART / Market

IART exceeded the US Market which returned 0.66% over the last twenty four hours.
warning

IART / Healthcare Sector

IART lose to the US Healthcare sector which returned 2.53% over the last twenty four hours.

Integra LifeSciences Holdings (IART) Statistics

Integra LifeSciences Holdings Corp (IART) is a leading global provider of regenerative technologies, neurosurgical and extremity orthopedic solutions. The company is dedicated to improving the quality of life for patients and has a strong focus on innovation and scientific advancements. With a market capitalization of over $4 billion, IART is a trusted name in the healthcare industry.
When it comes to valuation metrics, IART has some impressive numbers. The stock trades at a price-to-earnings ratio of 30.4, which is slightly higher than the sector average. However, when compared to its peers, IART's valuation appears to be in line with the industry. Additionally, the price-to-sales ratio of 3.2 indicates that the stock is reasonably priced.
add Integra LifeSciences Holdings to watchlist

Keep an eye on Integra LifeSciences Holdings

Adding the right stocks to your watchlist can provide valuable insights and opportunities for strategic decision-making.

Frequently Asked Questions

search
help

How much debt does Integra LifeSciences Holdings (IART) have?

Integra LifeSciences Holdings (IART) has a total debt of $1.99B. The net debt, which accounts for cash and cash equivalents against the total debt, is $1.77B.
help

How has Integra LifeSciences Holdings (IART) stock's performance compared to its sector and the market over the past year?

Over the past year, Integra LifeSciences Holdings (IART) has experienced a price change of . Compared to the Healthcare sector, which saw a change of 22.58%, Integra LifeSciences Holdings has underperformed compared to its sector, indicating its relative standing within the Healthcare sector. Against the broader market's change of 50.22%, it has fallen short of the market average. This comparison highlights Integra LifeSciences Holdings's performance relative to both its sector and the overall market over the last year.
help

What is the PE ratio of Integra LifeSciences Holdings (IART) stock?

The PE ratio for Integra LifeSciences Holdings (IART) is currently not available. This could be due to a variety of factors such as the company not having positive earnings at the moment or recent updates not being reflected.
help

What is the EPS of Integra LifeSciences Holdings (IART) stock?

The Earnings Per Share (EPS) for Integra LifeSciences Holdings (IART), calculated on a diluted basis, is -$0.09. EPS is a key indicator of a company's profitability, showing the portion of a company's profit allocated to each outstanding share of common stock.
help

What is the operating margin of Integra LifeSciences Holdings (IART) stock?

The operating margin for Integra LifeSciences Holdings (IART) is 6.6%. This metric represents the percentage of revenue that remains after paying for variable production costs, indicating the efficiency and profitability of the company's core business operations.
help

What is the EBITDA of Integra LifeSciences Holdings (IART) stock?

The EBITDA (Earnings Before Interest, Taxes, Depreciation, and Amortization) of Integra LifeSciences Holdings (IART) is $187.77M. EBITDA is a widely used earnings metric to assess a company's operational efficiency and profitability before the impact of non-operating decisions such as financing, accounting, and tax environments.

Take Your Investments to a Whole New Level